| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
Servizio Oncologia Sperimentale E, Istituto Nazionale Tumori, 80131 Naples, Italy [G. B., A. B., P. B., T. A., B. B., M. L. M., G. V.]; Cattedra Oncologia Medica, c/o Dipartimento di Oncologia ed Endocrinologia Molecolare e Clinica [C. S., S. P.] and Dipartimento di Biologia e Patologia Cellulare e Molecolare "L.Califano" [M. V. B.], Facoltà di Medicina e Chirurgia, Università di Napoli "Federico II," 80131 Naples, Italy; and Dipartimento di Medicina Sperimentale e Clinica, Facoltà di Medicina e Chirurgia di Catanzaro, Università Magna Graecia, 88100 Catanzaro, Italy [A. F.]
Abstract
Retinoic acid (RA) treatment of embryonal carcinoma cell line NTERA-2 clone D1 (NT2/D1) induces growth arrest and terminal differentiation along the neuronal pathway. In the present study, we provide a functional link between RA and p27 function in the control of neuronal differentiation in NT2/D1 cells. We report that RA enhances p27 expression, which results in increased association with cyclin E/cyclin-dependent kinase 2 complexes and suppression of their activity; however, antisense clones, which have greatly reduced RA-dependent p27 inducibility (NT2-p27AS), continue to synthesize DNA and are unable to differentiate properly in response to RA as determined by lack of neurite outgrowth and by the failure to modify surface antigens. As to the mechanism involved in RA-dependent p27 up-regulation, our data support the concept that RA reduces p27 protein degradation through the ubiquitin/proteasome-dependent pathway. Taken together, these findings demonstrate that in embryonal carcinoma cells, p27 expression is required for growth arrest and proper neuronal differentiation.
This article has been cited by other articles:
![]() |
A. Borriello, V. Cucciolla, M. Criscuolo, S. Indaco, A. Oliva, A. Giovane, D. Bencivenga, A. Iolascon, V. Zappia, and F. Della Ragione Retinoic Acid Induces p27Kip1 Nuclear Accumulation by Modulating Its Phosphorylation. Cancer Res., April 15, 2006; 66(8): 4240 - 4248. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guidoboni, P. Zancai, R. Cariati, S. Rizzo, J. Dal Col, A. Pavan, A. Gloghini, M. Spina, A. Cuneo, F. Pomponi, et al. Retinoic Acid Inhibits the Proliferative Response Induced by CD40 Activation and Interleukin-4 in Mantle Cell Lymphoma Cancer Res., January 15, 2005; 65(2): 587 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Porter, M. Kong-Beltran, and D. J. Donoghue Spy1 Interacts with p27Kip1 to Allow G1/S Progression Mol. Biol. Cell, September 1, 2003; 14(9): 3664 - 3674. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Rideout, Q. Wang, D. S. Park, and L. Stefanis Cyclin-Dependent Kinase Activity Is Required for Apoptotic Death But Not Inclusion Formation in Cortical Neurons after Proteasomal Inhibition J. Neurosci., February 15, 2003; 23(4): 1237 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Preclikova, V. Bryja, J. Pachernik, P. Krejci, P. Dvorak, and A. Hampl Early Cycling-independent Changes to p27, Cyclin D2, and Cyclin D3 in Differentiating Mouse Embryonal Carcinoma Cells Cell Growth Differ., September 1, 2002; 13(9): 421 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bastien, S. Adam-Stitah, J.-L. Plassat, P. Chambon, and C. Rochette-Egly The Phosphorylation Site Located in the A Region of Retinoic X Receptor alpha Is Required for the Antiproliferative Effect of Retinoic Acid (RA) and the Activation of RA Target Genes in F9 Cells J. Biol. Chem., August 2, 2002; 277(32): 28683 - 28689. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Legrier, A. Ducray, A. Propper, M. Chao, and A. Kastner Cell Cycle Regulation during Mouse Olfactory Neurogenesis Cell Growth Differ., December 1, 2001; 12(12): 591 - 601. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |